By driving the formation of the fibrotic barrier, YAP/TAZ activity in the TME directly contributes to the establishment of an immunologically ‘cold’ tumor phenotype, shielding cancer cells from immune surveillance and destruction41. The gene discussed is YAP1; the disease is cancer.